<DOC>
	<DOCNO>NCT00961025</DOCNO>
	<brief_summary>This dose block-randomized , double-blind , placebo-controlled , single/multiple dosing , dose-escalation study . The study design describe relationship multiple dos pharmacokinetic/pharmacodynamic parameter DA-1229 well safety profile .</brief_summary>
	<brief_title>A Study Characterize Pharmacokinetics/Pharmacodynamics Effect Food DA-1229 Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>2045 year healthy male subject Body weight :5090kg , BMI 18.525 Blood glucose level 70110mg/dL FPG test family history diabetes Serum AST ( SGOT ) , ALT ( SGPT ) &gt; 1.25 time upper limit normal Creatinine clearance rate &lt; 80mL/min show SBP = &lt; 100mmHg &gt; =150mmHg , DBP= &lt; 65mmHg &gt; =95mmHg , tachycardia ( PR &gt; =100times/min ) history drug abuse show positive drug abuse cotinine urine screen smoker digest highfat highcalorie food ( applicable 10mg dose group subject</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>